| BIOGEN INC. DL -,0005 | 232.100 / -0.21% |
| Date/Time | 08/05 / 22:59 |
| Chg. / Chg.(%) | -0.500 / -0.21% |
| Bid | 232.100 |
| Ask | 234.400 |
| Open | 232.600 |
| Previous Close | 232.600 |
| High | 236.600 |
| Low | 228.300 |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | 22779 |
| ISIN | US09062X1037 |
| Security | IDP |
| Exchange | Lang & Schwarz |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 276.1700 |  |
903,110 |
| IEX | 276.31 | |
36,815 |
| Cboe US | 276.22 | |
33,745 |
| TradeGate | 232.750 | |
1,913 |
| Xetra | 232.15 |  |
499 |
| Vienna Globa.. | 232.00 | |
179 |
| London Inter.. | 275.22 | |
94 |
| Frankfurt | 231.1000 | |
88 |
| gettex | 232.550 | |
10 |
| Stuttgart | 232.250 | |
5 |
| München | 233.10 | |
0 |
| Hamburg | 233.45 | |
0 |
| Düsseldorf | 231.85 | |
0 |
| Berlin | 231.95 | |
0 |
| Hannover | 233.45 | |
0 |
| SIX Swiss Ex.. | 232.00 | |
|
| Lang & Schwa.. | 232.100 | |
|
| Mexico | 6,007.47 | 16 |
News
- Biogen to Present Data at Virtual 2020 Alzheimer’s Association International Conference Highlighting Comprehensive Approach to Alzheimer’s Disease
07/24/2020 / 22:06 - GlobeNewswire - Biogen tops estimates with revenue of $3.7B in Q2
07/22/2020 / 12:52 - TeleTrader - Biogen Names Michael McDonnell as Executive Vice President and Chief Financial Officer
07/22/2020 / 00:00 - GlobeNewswire - Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated with Zolgensma® (onasemnogene abeparvovec)
07/21/2020 / 13:30 - GlobeNewswire - The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS
07/08/2020 / 23:01 - GlobeNewswire
Real-time